Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PHYLLOCONTIN

AMINOPHYLLINE

Standard Dose
225MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PHYLLOCONTIN is listed in Drugs@FDA under application 086760 (ANDA).

Marketing status: Discontinued Active ingredient AMINOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 225MG Sponsor PHARM RES ASSOC Submission history Latest submission status date: 1997-03-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview PHYLLOCONTIN is listed in Drugs@FDA under application 086760 (ANDA). Marketing status: Discontinued Active ingredient AMINOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 225MG Sponsor PHARM RES ASSOC Submission history Latest submission status date: 1997-03-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.